Carregant...
The Impact of PD-L1 Expression in Patients with Metastatic GEP-NETs
Programmed death-ligand 1 (PD-L1), which is expressed on many cancer cells, interacts with PD1 expressed on the surface of T cells, inhibiting the T cells and blocking the antitumor immune response. Expression of PD-L1 in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has not been studied....
Guardat en:
| Publicat a: | J Cancer |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4780123/ https://ncbi.nlm.nih.gov/pubmed/26958083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.13711 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|